John Larsen

John Larsen


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
DODavid P. J. Osborn
David P. J. Osborn
SHSarah Hardoon
Sarah Hardoon
RORumana Z. Omar
Rumana Z. Omar
RHRichard I. G. Holt
Richard I. G. Holt
MKMichael King
Michael King
IPIrene Petersen
Irene Petersen
It is well established that people with severe mental illnesses (SMIs), such as schizophrenia and bipolar disorder, have excess rates of cardiovascular disease (CVD), including myocardial infarctions and strokes.1 The risk of dying from CVD is 3-fold higher in people with SMI younger than 50 years and 2-fold in those aged 50 to 75 years.2 There has been an increase in clinical and research efforts addressing this problem, but we lack knowledge regarding the most effective ways to predict and manage cardiovascular risk in people with SMI. We know that the conventional cardiovascular risk factors, including smoking, dyslipidemia (with higher levels of total cholesterol and triglycerides and lower levels of high-density lipoprotein cholesterol [HDL-C]), diabetes mellitus, and obesity and possibly a higher prevalence of hypertension, are more common in people with SMI,3,4 especially those with well-established mental disorders.5 There may even be a shared genetic predisposition to comorbidities in patients with SMI. People with SMI are less likely to exercise, have unhealthy diets, and may receive inferior physical health care.6 Antipsychotic medications may contribute to cardiovascular risk through weight gain and its effect on glucose and lipid metabolism, although mortality studies2,7,8 that explore the role of antipsychotic medication in premature deaths show inconsistent findings. For example, an 11-year follow up study of people with schizophrenia7 reported reduced cardiovascular mortality in people treated with olanzapine and clozapine, but methodological issues in the study, particularly unmeasured confounding, have been critiqued in detail.9

10 February 2012 in Social Psychiatry and Psychiatric Epidemiology
Verified
Journal Article
Closed access
PDF file
JWJ. Williams
J. Williams
MLMary Leamy
Mary Leamy
VBV. Bird
V. Bird
CHC. Harding
C. Harding
JLJohn Larsen
John Larsen
MSMike Slade
Mike Slade

20 November 2007 in Journal of Clinical Nursing
Verified
Journal Article
Closed access
PDF file
JLJohn Larsen
John Larsen

17 May 2017 in BMC Public Health
Verified
Journal Article
Open access
PDF file
SASophie Attwood
Sophie Attwood
HPHannah Parke
Hannah Parke
JLJohn Larsen
John Larsen
KMKatie L. Morton
Katie L. Morton
Smartphone applications (“apps”) offer promise as tools to help people monitor and reduce their alcohol consumption. To date, few evaluations of alcohol reduction apps exist, with even fewer considering apps already available to the public. The aim of this study was to evaluate an existing publically available app, designed by Drinkaware, a UK-based alcohol awareness charity. We adopted a mixed-methods design, analysing routinely collected app usage data to explore user characteristics and patterns of usage. Following this, in-depth interviews were conducted with a sub-sample of app users to examine perceptions of acceptability, usability and perceived effectiveness, as well as to provide recommendations on how to improve the app. One hundred nineteen thousand seven hundred thirteen people downloaded and entered data into the app over a 13-month period. High attrition was observed after 1 week. Users who engaged with the app tended to be “high risk” drinkers and to report being motivated “to reduce drinking” at the point of first download. In those who consistently engaged with the app over time, self-reported alcohol consumption levels reduced, with most change occurring in the first week of usage. Our qualitative findings indicate satisfaction with the usability of the app, but mixed feedback was given regarding individual features. Users expressed conflicting views concerning the type of feedback and notifications that the app currently provides. A common preference was expressed for more personalised content. The Drinkaware app is a useful tool to support behaviour change in individuals who are already motivated and committed to reducing their alcohol consumption. The Drinkaware app would benefit from greater personalisation and tailoring to promote longer term use. This evaluation provides insight into the usability and acceptability of various app features and contains a number of recommendations for improving user satisfaction and the potential effectiveness of apps designed to encourage reductions in alcohol consumption.

19 August 2014 in Administration and Policy in Mental Health and Mental Health Services Research
Verified
Journal Article
Closed access
PDF file
CBClair Le Boutillier
Clair Le Boutillier
MSMike Slade
Mike Slade
VLVanessa Lawrence
Vanessa Lawrence
VBVictoria J. Bird
Victoria J. Bird
RCRuth Chandler
Ruth Chandler
MLMary Leamy
Mary Leamy

21 October 2014 in Administration and Policy in Mental Health and Mental Health Services Research
Verified
Journal Article
Closed access
PDF file
SGSteve Gillard
Steve Gillard
JHJess Holley
Jess Holley
SGSarah Gibson
Sarah Gibson
JLJohn Larsen
John Larsen
MLMike Lucock
Mike Lucock
ESElina Stamou
Elina Stamou